Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT05785377
NA

Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia

Sponsor: Mansoura University

View on ClinicalTrials.gov

Summary

Cesarean birth is a common surgical procedure. After cesarean birth, postsurgical pain may delay recovery, interfere with maternal-newborn bonding, and reduce the breastfeeding if not adequately controlled. Postpartum analgesia has become a common concern. Many adjuvant drugs used for peripheral nerve blocks as( N-methyl-d-aspartate (NMDA) receptor antagonists , Magnesium , Ephedrine , Dexamesathone , Fentanyl , Midazolam and Neostigmine) The potential of neostigmine as an adjuvant in peripheral nerve block is through its action to increase acetylcholine at muscarinic junctions of peripheral nerves. 500 mcg neostigmine was used as adjuvant to local anesthetic in an axillary brachial plexus block leads to decreased pain and less use of analgesics in the first 24 hours postoperatively with no incidence of adverse effects.

Official title: Efficacy of Neostigmine as an Adjuvant to Bupivacaine in Ultrasound-guided Transversus Abdominis Plane Block as a Postoperative Analgesia After Caesarean Delivery.

Key Details

Gender

FEMALE

Age Range

19 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

58

Start Date

2027-12-01

Completion Date

2029-12-01

Last Updated

2026-02-17

Healthy Volunteers

No

Conditions

Interventions

DRUG

Bupivacaine-Neostigmine

20 mL bupivacaine 0.25% plus 1 mL Neostigmine (500 mcg)

DRUG

Bupivacaine

20 mL bupivacaine 0.25% plus 1 mL normal saline 0.9%

Locations (1)

Mansoura University-Emergency hospital-ICU

El Mansoura, Mansoura, Egypt